[
  {
    "id": "metformin",
    "name": "Metformin",
    "searchTerms": ["metformin", "glucophage"],
    "className": "Biguanide, oral hypoglycaemic",
    "tags": ["Diabetes", "eGFR-based"],
    "usualDose": "Typical maintenance 1–2 g per day in divided doses, given with or after food.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "No dose change",
        "details": "Use usual dose. Monitor renal function at least yearly and before iodinated contrast or major surgery."
      },
      {
        "min": 45,
        "max": 60,
        "label": "eGFR 45–59 mL/min/1.73 m²",
        "category": "Caution / monitor",
        "details": "Standard doses are often acceptable but consider more frequent monitoring, for example every 3–6 months, and avoid starting in very high risk patients."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Reduce total daily dose and do not escalate. Monitor renal function at least every 3 months and stop during acute illness or dehydration."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30 mL/min/1.73 m²",
        "category": "Avoid / stop",
        "details": "Avoid metformin because of risk of accumulation and lactic acidosis. Use an alternative glucose lowering regimen."
      }
    ],
    "notes": [
      "Check renal function before starting and at least yearly, more often if eGFR < 60 or if risk of deterioration.",
      "Stop metformin temporarily during acute illness, dehydration, sepsis or around iodinated contrast and major surgery.",
      "Use lower doses in frail or low body weight patients."
    ]
  },
  {
    "id": "gliclazide",
    "name": "Gliclazide",
    "searchTerms": ["gliclazide"],
    "className": "Sulfonylurea",
    "tags": ["Diabetes", "Hypoglycaemia risk"],
    "usualDose": "40–320 mg per day in 1–2 divided doses, titrated according to blood glucose. Modified release preparations are usually once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard dosing",
        "details": "Usual titration schedule may be used with monitoring for hypoglycaemia."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Caution / lower starting dose",
        "details": "Use a lower starting dose and titrate carefully. Risk of prolonged hypoglycaemia is higher."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Use with great caution",
        "details": "Prefer alternative agents. If used, start at very low dose and monitor closely for hypoglycaemia."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m² or dialysis",
        "category": "Generally avoid",
        "details": "Avoid sulfonylureas where possible and seek specialist diabetes advice."
      }
    ],
    "notes": [
      "Risk of hypoglycaemia increases as renal function declines.",
      "Review driving advice and sick day rules in people at higher risk."
    ]
  },
  {
    "id": "insulin-basal",
    "name": "Basal insulin (for example insulin glargine)",
    "searchTerms": ["insulin", "glargine", "lantus", "abasaglar", "basal insulin"],
    "className": "Basal insulin analogue",
    "tags": ["Diabetes", "No fixed renal schedule"],
    "usualDose": "Dose is fully individualised; once or twice daily regimens titrated to capillary or continuous glucose readings.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Individual titration",
        "details": "No fixed renal dose table. Insulin requirements often fall as eGFR declines because clearance is reduced; titrate to glucose readings."
      }
    ],
    "notes": [
      "Hypoglycaemia risk increases as renal function worsens.",
      "Review total daily dose regularly in people with progressive CKD or starting dialysis.",
      "Seek specialist diabetes input in advanced CKD."
    ]
  },
  {
    "id": "gabapentin",
    "name": "Gabapentin",
    "searchTerms": ["gabapentin", "neurontin"],
    "className": "Antiepileptic and neuropathic pain agent",
    "tags": ["Neuropathic pain", "Renally cleared"],
    "usualDose": "In normal renal function, typical maintenance is 900–3600 mg per day in three divided doses, titrated to response.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m² or CrCl ≥ 60 mL/min",
        "category": "No dose change",
        "details": "Standard titration and dose range may be used, up to local maximum."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Moderate reduction",
        "details": "Reduce total daily dose and or frequency, for example 600–1800 mg per day in 2–3 divided doses depending on creatinine clearance."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Significant reduction",
        "details": "Use lower daily doses, for example 300–600 mg per day in 1–2 doses, with slow titration. Monitor for sedation and dizziness."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m² or dialysis",
        "category": "Specialist dosing",
        "details": "Very low daily doses or post dialysis dosing only according to local renal or pain guidance."
      }
    ],
    "notes": [
      "Gabapentin is almost entirely renally excreted and can accumulate, causing ataxia and confusion.",
      "Dose by creatinine clearance where possible and monitor for central nervous system adverse effects.",
      "Use particular caution in older people, people with falls risk and those on other sedatives or opioids."
    ]
  },
  {
    "id": "pregabalin",
    "name": "Pregabalin",
    "searchTerms": ["pregabalin", "lyrica"],
    "className": "Antiepileptic and neuropathic pain or anxiety agent",
    "tags": ["Neuropathic pain", "Renally cleared"],
    "usualDose": "In normal renal function, usual adult dose range is 150–600 mg per day in 2–3 divided doses.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m² or CrCl ≥ 60 mL/min",
        "category": "No dose change",
        "details": "Standard dose range may be used, titrated to response and tolerability."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Use lower maximum daily dose, for example up to around 300 mg per day in divided doses, in line with SPC or BNF."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Marked reduction",
        "details": "Use substantially reduced doses, for example up to about 150 mg per day, with cautious titration."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m² or dialysis",
        "category": "Specialist dosing",
        "details": "Very low doses only, often once daily or post dialysis, under specialist guidance."
      }
    ],
    "notes": [
      "Pregabalin is renally cleared; accumulation increases risk of dizziness, somnolence and peripheral oedema.",
      "Consider falls risk and concomitant central nervous system depressants.",
      "Taper slowly when stopping to reduce withdrawal symptoms."
    ]
  },
  {
    "id": "allopurinol",
    "name": "Allopurinol",
    "searchTerms": ["allopurinol"],
    "className": "Xanthine oxidase inhibitor",
    "tags": ["Gout", "Urate lowering"],
    "usualDose": "Start at a low dose, for example 100 mg once daily, and titrate according to serum urate, often to 300–600 mg daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard initiation",
        "details": "Start at 100 mg once daily and titrate gradually, monitoring urate and for rash or hypersensitivity."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Lower starting dose",
        "details": "Use a lower starting dose, for example 50–100 mg once daily, and increase cautiously. Maximal doses may need to be lower."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Cautious use",
        "details": "Start at very low dose, such as 50 mg daily or 100 mg on alternate days, and titrate slowly with close monitoring."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m²",
        "category": "Specialist decision",
        "details": "Use only on specialist advice; consider alternative urate lowering options where appropriate."
      }
    ],
    "notes": [
      "Allopurinol hypersensitivity risk is higher with renal impairment and high starting doses; start low and increase slowly.",
      "Continue flare prophylaxis such as colchicine or NSAID where appropriate, adjusted for renal function.",
      "Aim for guideline serum urate targets and avoid stopping allopurinol during flares."
    ]
  },
  {
    "id": "colchicine",
    "name": "Colchicine",
    "searchTerms": ["colchicine"],
    "className": "Anti inflammatory for gout and pericarditis",
    "tags": ["Gout", "Narrow therapeutic index"],
    "usualDose": "For acute gout, typical dose is 500 micrograms two to four times daily with maximum total dose per course.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard short course",
        "details": "Use short courses only and avoid repeating within two weeks."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Reduce total dose per course and avoid frequent repeats because of toxicity risk."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Very cautious use",
        "details": "Prefer alternative therapy. If used, give very low doses with close monitoring for gastrointestinal symptoms and myopathy."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m²",
        "category": "Generally avoid",
        "details": "High risk of toxicity; avoid unless under specialist advice."
      }
    ],
    "notes": [
      "Colchicine has a narrow therapeutic index and toxicity risk is increased in CKD and with interacting drugs.",
      "Warn patients to stop and seek help if they develop severe diarrhoea, vomiting, muscle pain or weakness."
    ]
  },

  {
    "id": "ramipril",
    "name": "Ramipril",
    "searchTerms": ["ramipril"],
    "className": "ACE inhibitor",
    "tags": ["Heart failure", "Hypertension"],
    "usualDose": "Hypertension: 2.5–10 mg once daily. Heart failure: often start at 1.25–2.5 mg once daily and titrate to 5–10 mg daily as tolerated.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard titration",
        "details": "Start per indication and titrate to target while monitoring renal function and potassium."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Start low, go slow",
        "details": "Use lower starting dose and titrate cautiously. Review if creatinine rises more than about 30 percent or potassium is high."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Cautious use",
        "details": "Start at very low dose with close monitoring. May not be suitable in unstable CKD or bilateral renal artery stenosis."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m² or dialysis",
        "category": "Specialist decision",
        "details": "Use only on specialist nephrology or cardiology advice."
      }
    ],
    "notes": [
      "Check creatinine and potassium before starting and 1–2 weeks after dose changes.",
      "Stop temporarily during acute illness or dehydration according to sick day rules."
    ]
  },
  {
    "id": "losartan",
    "name": "Losartan",
    "searchTerms": ["losartan", "cozaar"],
    "className": "Angiotensin II receptor blocker",
    "tags": ["Hypertension", "Heart failure", "Diabetic nephropathy"],
    "usualDose": "Typical adult dose is 50–100 mg once daily. Use lower starting doses in heart failure, older adults or CKD.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard dosing",
        "details": "Start per indication and titrate while monitoring renal function and potassium."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Lower starting dose",
        "details": "Consider starting at 25–50 mg once daily and titrate slowly with frequent monitoring."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Cautious use",
        "details": "Consider specialist input; use low doses and monitor renal function and potassium closely."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m²",
        "category": "Specialist decision",
        "details": "Use only under specialist supervision."
      }
    ],
    "notes": [
      "ARB monitoring and precautions are similar to ACE inhibitors.",
      "Useful in diabetic nephropathy but requires careful monitoring of renal function and potassium."
    ]
  },
  {
    "id": "bisoprolol",
    "name": "Bisoprolol",
    "searchTerms": ["bisoprolol"],
    "className": "Beta 1 selective beta blocker",
    "tags": ["Heart failure", "Hypertension"],
    "usualDose": "Heart failure: start at 1.25 mg once daily and titrate to 10 mg once daily if tolerated. Hypertension: 5–10 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard titration",
        "details": "Use usual titration schedule with monitoring of heart rate and blood pressure."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "No major adjustment",
        "details": "Formal dose adjustment is usually not required but titrate cautiously in frail patients or severe heart failure."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Caution",
        "details": "Titrate slowly and monitor for bradycardia, hypotension and worsening heart failure."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m²",
        "category": "Specialist advice",
        "details": "Can often be continued at low doses; seek specialist advice in advanced CKD or dialysis."
      }
    ],
    "notes": [
      "Bisoprolol is partly renally cleared; accumulation can contribute to bradycardia and hypotension.",
      "Follow local heart failure titration protocols where available."
    ]
  },
  {
    "id": "furosemide",
    "name": "Furosemide",
    "searchTerms": ["furosemide", "frusemide"],
    "className": "Loop diuretic",
    "tags": ["Heart failure", "Oedema"],
    "usualDose": "Typical oral dose is 20–80 mg once or twice daily; higher doses are often needed in CKD or resistant oedema.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard dosing",
        "details": "Use the lowest effective dose for symptom control with monitoring of renal function and electrolytes."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "May need higher doses",
        "details": "Loop diuretics remain effective but higher doses may be required. Monitor for volume depletion and electrolyte disturbance."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "High doses often needed",
        "details": "Substantially higher doses or intravenous therapy may be needed under specialist supervision."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m² or dialysis",
        "category": "Specialist dosing",
        "details": "Doses are highly individualised; coordinate with renal or cardiology teams."
      }
    ],
    "notes": [
      "Volume depletion in CKD can precipitate acute kidney injury; adjust doses according to weight, fluid status and blood results.",
      "Monitor sodium, potassium and magnesium regularly."
    ]
  },
  {
    "id": "spironolactone",
    "name": "Spironolactone",
    "searchTerms": ["spironolactone"],
    "className": "Aldosterone antagonist",
    "tags": ["Heart failure", "Hyperkalaemia risk"],
    "usualDose": "Heart failure: usually 25–50 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard low dose use",
        "details": "Use typical doses with monitoring of creatinine and potassium."
      },
      {
        "min": 45,
        "max": 60,
        "label": "eGFR 45–59 mL/min/1.73 m²",
        "category": "Caution",
        "details": "Consider lower doses, such as 25 mg on alternate days, and very close potassium monitoring."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44 mL/min/1.73 m²",
        "category": "High hyperkalaemia risk",
        "details": "Often avoid or use only very low doses with specialist advice and frequent blood tests."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30 mL/min/1.73 m²",
        "category": "Generally avoid",
        "details": "Markedly increased hyperkalaemia risk; usually avoided outside specialist settings."
      }
    ],
    "notes": [
      "Check creatinine and potassium at baseline, after 1 week and after dose changes, then regularly.",
      "Reduce dose or stop if potassium is persistently high or creatinine rises substantially."
    ]
  },

  {
    "id": "apixaban",
    "name": "Apixaban",
    "searchTerms": ["apixaban", "eliquis", "doac"],
    "className": "Direct factor Xa inhibitor",
    "tags": ["DOAC", "Stroke prevention in AF"],
    "usualDose": "For non valvular atrial fibrillation, typical dose is 5 mg twice daily, reduced to 2.5 mg twice daily if dose reduction criteria are met.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "CrCl ≥ 50 mL/min (approx eGFR ≥ 50)",
        "category": "Standard DOAC dosing",
        "details": "Use standard licensed dose per indication, checking current SPC and SPS guidance."
      },
      {
        "min": 30,
        "max": 50,
        "label": "CrCl 30–49 mL/min",
        "category": "Caution / consider reduction",
        "details": "Apixaban is often preferred DOAC in moderate CKD. For atrial fibrillation, reduced dose may be appropriate if other criteria are met."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15–29 mL/min",
        "category": "Reduced dose / specialist advice",
        "details": "For atrial fibrillation, reduced dose is often recommended with caution. VTE treatment at this clearance usually needs specialist decision."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 mL/min or dialysis",
        "category": "Generally avoid",
        "details": "Most UK guidance advises avoiding DOACs if creatinine clearance is below 15 mL/min."
      }
    ],
    "notes": [
      "Dose DOACs using Cockcroft Gault creatinine clearance rather than eGFR.",
      "Check renal function at baseline and at least yearly, more often in older or frail patients.",
      "Always check current SPC, SPS DOAC guidance and local protocols."
    ]
  },
  {
    "id": "rivaroxaban",
    "name": "Rivaroxaban",
    "searchTerms": ["rivaroxaban", "xarelto", "doac"],
    "className": "Direct factor Xa inhibitor",
    "tags": ["DOAC", "Stroke prevention in AF"],
    "usualDose": "For non valvular atrial fibrillation, typical dose is 20 mg once daily with food, reduced to 15 mg once daily if creatinine clearance is 15–49 mL/min.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "CrCl ≥ 50 mL/min",
        "category": "Standard dosing",
        "details": "Use standard licensed dose according to indication."
      },
      {
        "min": 15,
        "max": 50,
        "label": "CrCl 15–49 mL/min",
        "category": "Reduced dose / caution",
        "details": "Reduced dose is recommended for atrial fibrillation. Avoid if creatinine clearance is below 15 mL/min."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 mL/min",
        "category": "Avoid",
        "details": "Avoid rivaroxaban and consider warfarin or specialist guided options."
      }
    ],
    "notes": [
      "Dose using creatinine clearance and check SPC or SPS guidance.",
      "Monitor renal function regularly in people on rivaroxaban."
    ]
  },

  {
    "id": "amoxicillin",
    "name": "Amoxicillin",
    "searchTerms": ["amoxicillin"],
    "className": "Aminopenicillin antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "Typical adult dose is 500 mg three times daily, with higher doses for severe infection.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30 mL/min/1.73 m²",
        "category": "Standard dosing",
        "details": "Use usual dosing interval according to indication."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10–29 mL/min/1.73 m²",
        "category": "Extended interval",
        "details": "Consider reducing frequency, for example 500 mg twice daily, depending on severity and site of infection."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 mL/min/1.73 m² or dialysis",
        "category": "Further reduction / specialist advice",
        "details": "Use lower doses or prolonged intervals and seek renal or microbiology advice for serious infection."
      }
    ],
    "notes": [
      "Amoxicillin is generally safe in CKD but can accumulate at very low eGFR.",
      "Follow local antimicrobial guidelines for indications and dose."
    ]
  },
  {
    "id": "co-amoxiclav",
    "name": "Co-amoxiclav",
    "searchTerms": ["co-amoxiclav", "amoxicillin clavulanic"],
    "className": "Amoxicillin plus clavulanic acid",
    "tags": ["Antibiotic"],
    "usualDose": "Typical adult dose is 500 mg or 875 mg of amoxicillin with clavulanic acid twice or three times daily depending on preparation and indication.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30 mL/min/1.73 m²",
        "category": "Standard dosing",
        "details": "Use usual dose according to indication."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10–29 mL/min/1.73 m²",
        "category": "Extended interval",
        "details": "Reduce frequency, for example to twice daily dosing, according to local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 mL/min/1.73 m² or dialysis",
        "category": "Further reduction / consider alternative",
        "details": "Use lower doses or alternative agents; seek local renal or antimicrobial advice."
      }
    ],
    "notes": [
      "Watch for cholestatic liver injury, particularly with increasing age.",
      "Use according to local antimicrobial formulary."
    ]
  },
  {
    "id": "nitrofurantoin",
    "name": "Nitrofurantoin",
    "searchTerms": ["nitrofurantoin", "macrobid"],
    "className": "Urinary antibacterial",
    "tags": ["UTI", "Avoid at low eGFR"],
    "usualDose": "For uncomplicated lower UTI, typical adult dose is 100 mg modified release twice daily or 50 mg four times daily for 3–7 days.",
    "renalBands": [
      {
        "min": 45,
        "max": null,
        "label": "eGFR ≥ 45 mL/min/1.73 m²",
        "category": "Standard use",
        "details": "Can be used for short course treatment of lower UTI if no evidence of upper tract infection."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44 mL/min/1.73 m²",
        "category": "Short course only / caution",
        "details": "Some guidance allows short courses in this range if benefits outweigh risks; avoid long term prophylaxis."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30 mL/min/1.73 m²",
        "category": "Avoid",
        "details": "Avoid nitrofurantoin because urinary concentrations are inadequate and toxicity risk increases."
      }
    ],
    "notes": [
      "Do not use for suspected upper UTI or systemic sepsis.",
      "Avoid long term prophylaxis in CKD and in people with significant lung disease."
    ]
  },
  {
    "id": "trimethoprim",
    "name": "Trimethoprim",
    "searchTerms": ["trimethoprim"],
    "className": "Dihydrofolate reductase inhibitor antibiotic",
    "tags": ["UTI", "Hyperkalaemia risk"],
    "usualDose": "Typical adult dose is 200 mg twice daily for 3–7 days in uncomplicated UTI; lower doses are used for prophylaxis.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30 mL/min/1.73 m²",
        "category": "Standard short course",
        "details": "Use usual short course doses; consider lower doses in older or frail patients."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Reduce total dose, for example 200 mg once daily or extend dose interval."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m²",
        "category": "Avoid / specialist advice",
        "details": "Avoid where possible because of accumulation, hyperkalaemia and risk of acute kidney injury."
      }
    ],
    "notes": [
      "Trimethoprim can increase creatinine and potassium, particularly with ACE inhibitors, ARBs or spironolactone.",
      "Check renal function and electrolytes if used in CKD or with interacting medicines."
    ]
  },
  {
    "id": "cefalexin",
    "name": "Cefalexin",
    "searchTerms": ["cefalexin", "cephalexin"],
    "className": "First generation cephalosporin",
    "tags": ["Antibiotic"],
    "usualDose": "Typical adult dose is 500 mg two to four times daily depending on indication.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR ≥ 50 mL/min/1.73 m²",
        "category": "Standard dosing",
        "details": "Use usual dosing interval for indication and severity."
      },
      {
        "min": 10,
        "max": 50,
        "label": "eGFR 10–49 mL/min/1.73 m²",
        "category": "Extended interval",
        "details": "Reduce frequency, for example 500 mg twice daily, according to infection severity and local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 mL/min/1.73 m²",
        "category": "Further reduction",
        "details": "Consider 500 mg once daily or alternative agents as per renal dosing tables."
      }
    ],
    "notes": [
      "Cephalosporins are mainly renally cleared and can accumulate at low eGFR, increasing risk of neurotoxicity.",
      "Follow local UTI and skin or soft tissue infection guidelines."
    ]
  },
  {
    "id": "ciprofloxacin",
    "name": "Ciprofloxacin",
    "searchTerms": ["ciprofloxacin", "cipro"],
    "className": "Fluoroquinolone antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "Typical adult oral dose is 250–750 mg twice daily depending on infection and severity.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard dosing",
        "details": "Use dose according to indication and local guidance; avoid unnecessary use because of resistance and side effects."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Consider reducing dose or frequency, for example 250–500 mg twice daily, in line with BNF and local protocols."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30 mL/min/1.73 m²",
        "category": "Further reduction / specialist advice",
        "details": "Use lower doses or extended intervals and seek microbiology advice for serious infections."
      }
    ],
    "notes": [
      "Fluoroquinolones carry risks of tendon rupture, neuropathy and QT prolongation; reserve for appropriate indications.",
      "Use with caution in patients with previous tendon disorders, epilepsy or concurrent QT prolonging drugs."
    ]
  },

  {
    "id": "digoxin",
    "name": "Digoxin",
    "searchTerms": ["digoxin"],
    "className": "Cardiac glycoside",
    "tags": ["Heart failure", "Rate control", "Narrow therapeutic index"],
    "usualDose": "Typical maintenance dose is 62.5–250 micrograms once daily depending on age, renal function and indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard cautious dosing",
        "details": "Use lower maintenance doses in older adults and those at risk of toxicity."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Use reduced maintenance dose, often 62.5–125 micrograms daily or on alternate days, with level monitoring."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Marked reduction",
        "details": "Use very low doses such as 62.5 micrograms daily or on alternate days, and monitor levels regularly."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m²",
        "category": "Specialist dosing",
        "details": "Use only with digoxin level monitoring and specialist supervision."
      }
    ],
    "notes": [
      "Digoxin is renally cleared and toxicity risk is higher in CKD, hypokalaemia and hypomagnesaemia.",
      "Monitor digoxin levels and electrolytes if toxicity is suspected."
    ]
  },
  {
    "id": "aciclovir",
    "name": "Aciclovir (oral)",
    "searchTerms": ["aciclovir", "acyclovir"],
    "className": "Antiviral",
    "tags": ["Antiviral"],
    "usualDose": "Typical oral dose is 400–800 mg three to five times daily depending on indication, such as herpes simplex or shingles.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR ≥ 50 mL/min/1.73 m²",
        "category": "Standard dosing",
        "details": "Use usual dose and frequency according to indication."
      },
      {
        "min": 10,
        "max": 50,
        "label": "eGFR 10–49 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Reduce frequency, for example 800 mg twice daily for shingles, in line with BNF or SPC."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 mL/min/1.73 m² or dialysis",
        "category": "Further reduction / specialist advice",
        "details": "Substantially reduce dose or extend intervals and seek specialist advice for systemic infection."
      }
    ],
    "notes": [
      "Aciclovir can cause crystal nephropathy and neurotoxicity at high doses, especially in CKD or dehydration.",
      "Advise good oral fluid intake and adjust dose at low eGFR."
    ]
  },

  {
    "id": "morphine-oral",
    "name": "Morphine (oral)",
    "searchTerms": ["morphine"],
    "className": "Opioid analgesic",
    "tags": ["Opioid", "Avoid in severe CKD if possible"],
    "usualDose": "Immediate release and modified release preparations are used. Dose depends on indication and previous opioid exposure.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard cautious dosing",
        "details": "Titrate short acting morphine to effect then convert to modified release if appropriate."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Use lower doses",
        "details": "Morphine metabolites accumulate; use reduced doses and or longer intervals. Monitor for sedation and confusion."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Avoid if possible",
        "details": "Avoid regular morphine if alternatives are suitable. If used, give very low doses with close monitoring."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m² or dialysis",
        "category": "Do not use",
        "details": "Morphine and active metabolites accumulate markedly; use alternative opioids under specialist advice."
      }
    ],
    "notes": [
      "Morphine 6 glucuronide accumulates in CKD and can cause profound sedation and respiratory depression.",
      "Consider alternative opioids such as fentanyl or alfentanil in severe CKD under palliative care or pain team guidance."
    ]
  },
  {
    "id": "oxycodone-oral",
    "name": "Oxycodone (oral)",
    "searchTerms": ["oxycodone"],
    "className": "Opioid analgesic",
    "tags": ["Opioid"],
    "usualDose": "Dose depends on indication and previous opioid exposure. Use opioid conversion tables when switching from morphine.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "Standard cautious dosing",
        "details": "Titrate dose to effect. Use similar precautions to morphine regarding sedation and constipation."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Use lower starting doses and or longer intervals compared with normal renal function."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29 mL/min/1.73 m²",
        "category": "Marked reduction / consider alternatives",
        "details": "Further reduce doses and monitor closely for sedation and confusion; consider switching to a more suitable opioid if problems occur."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 mL/min/1.73 m² or dialysis",
        "category": "Specialist advice",
        "details": "Use only under specialist guidance, often at very low doses or with alternative opioids preferred."
      }
    ],
    "notes": [
      "Oxycodone metabolites are renally cleared and can accumulate; it may be preferred to morphine in moderate CKD but still needs dose reduction.",
      "Use your opioid conversion and renal tools together when switching opioids."
    ]
  }
]
